BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Prescription Drug Price Hikes Help Fuel Massive 32 Percent Boost to Profits… Read More
© 2026 CSRXP- All Rights Reserved
CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST
Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision… Read More
WHAT THEY ARE SAYING: LOWERING Rx PRICES & HOLDING BIG PHARMA ACCOUNTABLE TOP PRIORITY IN 2020
Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions… Read More
BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S 2020 PRICE HIKE BONANZA
News from First Weeks of New Year Underscores Urgent Need for Action in… Read More
CSRXP: BIG PHARMA THUMBS ITS NOSE AT STRUGGLING AMERICANS WITH NEW YEAR PRICE HIKES
Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More… Read More
CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More
Big Pharma’s Price-Gouging and Anti-Competitive Tactics Drive Increased Rx Spending
CMS Report Demonstrates Impact of Out-of-Control Launch Prices and Tactics… Read More
CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB
Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress… Read More
CSRXP APPLAUDS USMCA CHANGES TO PUT AMERICAN PATIENTS FIRST
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington… Read More
CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D
Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times… Read More
BIG PHARMA WATCH: NEW STUDY FINDS PRICE HIKES DRIVEN BY QUEST FOR HIGHER PROFITS, NOT R&D
Analysis of Multiple Sclerosis Drug Pricing Undercuts Drug Makers’ Bogus… Read More
ICYMI: Political Courage Needed to Deliver on Drug Prices
Political Courage Needed to Deliver on Drug Prices By Lauren Aronson Real… Read More